Nucleus Capital
InvestorActiveNucleus Capital is a Berlin-based deep-tech venture firm founded in 2021 with EUR 40 million in capital targeting programmable biology, synthetic biology, agricultural technology, and green industrials at the pre-seed stage. The firm invests in founders with strong scientific pedigrees-80% of its portfolio cofounder have PhDs-who are pioneering novel biotechnology solutions for food production and industrial manufacturing. Nucleus provides capital up to EUR 1 million alongside mentorship from leading scientists and biotech operators to accelerate commercialization of biology-based solutions.
Founder Intel
Sign in to read intel from founders who have worked with Nucleus Capital.
What founders say about Nucleus Capital
Be the first to share intel on Nucleus Capital — it's free.
Get Started FreeRelated on The List
- Seattle Angel Conference — Investor · N America
- Avaana Capital — Investor · India
- Blue Ashva Capital — Investor · Singapore, Singapore
- Cloudberry Ventures — Investor · London, United Kingdom
- Eka Ventures — Investor · United Kingdom
Comparing options? Founders discuss fundraising in the forum, or browse the rest of The List.